Sector portfolio · VC firm · United States
Wellington Management's Pharma portfolio
Wellington Management has backed 11 Pharma startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Korsana Biosciences.
Wellington Management's whole portfolioWellington Management's profile
Funding by segment
- Series C and later$650M3
- Series A$633M3
- Stage not reported$402M3
- Series B$550M2
Where they are based
- United States11$2.2B
United StatesFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M2
- $50M to $250M6
- $250M to $1B3
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
8 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States11
Startups by country, 1 country in all.
Segment by segment
Series C and later
3 startups · $650M raised
Zenas BioPharmaZenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.United States$420M
Angitia BiopharmaceuticalsAngitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, dedicated to developing innovative therapiesUnited States$130M
Avalyn PharmaAvalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.United States$100M
Series A
3 startups · $633M raised
Korsana BiosciencesKorsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.United States$530M
Helicore BiopharmaHelicore Biopharma is a private biopharmaceutical company based in San Mateo, California, focused on developing innovative weight-United States$65M
Caldera TherapeuticsCaldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).United States$38M
Stage not reported
3 startups · $402M raised
Edgewise TherapeuticsEdgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.United States$200M
Day One BiopharmaceuticalsDay One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.United States$175M
Ventyx BiosciencesVentyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.United States$27M
Series B
2 startups · $550M raised
- CTCrystalys TherapeuticsUnited States$335M
MetseraMetsera operates as a clinical-stage biopharmaceutical company.United States$215M
How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Wellington Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Wellington Management?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.